These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. A cAMP binding abnormality in psoriasis. Raynaud F; Gerbaud P; Enjolras O; Gorin I; Donnadieu M; Anderson WB; Evain-Brion D Lancet; 1989 May; 1(8648):1153-6. PubMed ID: 2566733 [TBL] [Abstract][Full Text] [Related]
49. Abnormalities of the liver evaluated by 31P MRS. Meyerhoff DJ; Karczmar GS; Weiner MW Invest Radiol; 1989 Dec; 24(12):980-4. PubMed ID: 2606636 [TBL] [Abstract][Full Text] [Related]
50. Phosphorus metabolism during growth of lymphoma in mouse liver: a comparison of 31P magnetic resonance spectroscopy in vivo and in vitro. Thomas CP; Dixon RM; Tian M; Butler SA; Counsell CJ; Bradley JK; Adams GE; Radda GK Br J Cancer; 1994 Apr; 69(4):633-40. PubMed ID: 8142251 [TBL] [Abstract][Full Text] [Related]
51. Etretinate therapy stimulates deposition of mucus-like material in epidermis of patients with psoriasis. Ellis CN; Gold RC; Grekin RC; Anderson TF; Swanson NA; Voorhees JJ J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):699-704. PubMed ID: 7068978 [TBL] [Abstract][Full Text] [Related]
52. Hypothalamic-pituitary-adrenal axis suppression related to topical glucocorticoid therapy in a child with psoriatic exfoliative erythroderma. Campbell LS; Chevalier M; Levy RA; Rhodes A Pediatr Dermatol; 2012; 29(1):101-4. PubMed ID: 21995486 [TBL] [Abstract][Full Text] [Related]
53. Etretinate therapy for psoriasis: clinical responses, remission times, epidermal DNA and polyamine responses. Kaplan RP; Russell DH; Lowe NJ J Am Acad Dermatol; 1983 Jan; 8(1):95-102. PubMed ID: 6826812 [TBL] [Abstract][Full Text] [Related]
54. Phosphorus metabolite characterization of human prostatic adenocarcinoma in a nude mouse model by 31P magnetic resonance spectroscopy and high pressure liquid chromatography. Kurhanewicz J; Dahiya R; Macdonald JM; Jajodia P; Chang LH; James TL; Narayan P NMR Biomed; 1992; 5(4):185-92. PubMed ID: 1449954 [TBL] [Abstract][Full Text] [Related]
55. Improved noninvasive diagnostic testing for malignant hyperthermia susceptibility from a combination of metabolites determined in vivo with 31P-magnetic resonance spectroscopy. Payen JF; Bosson JL; Bourdon L; Jacquot C; Le Bas JF; Stieglitz P; Benabid AL Anesthesiology; 1993 May; 78(5):848-55. PubMed ID: 8489056 [TBL] [Abstract][Full Text] [Related]
56. Proton-decoupled phosphorus-31 magnetic resonance spectroscopy in the evaluation of native and well-functioning transplanted kidneys. Vallée JP; Lazeyras F; Sostman HD; Smith SR; Butterly DW; Spritzer CE; Charles HC Acad Radiol; 1996 Dec; 3(12):1030-7. PubMed ID: 9017019 [TBL] [Abstract][Full Text] [Related]